BIOMAT Database Logo BIOMAT Database Logo

The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity. 1980

M Zakarija

The thyroid-stimulating antibody (TSAb) of Graves' disease was shown to have a relatively constant pH on preparative isoelectric focusing; the fraction of pH 8.5-9.0 was maximal in thyroid-stimulating potency but inhibition of thyrotropin-binding (another property of Graves' disease IgG) was most marked with pH 9.5-10.6 fraction. H and L chains of TSAb-IgG were separated and H original (HO) was combined with L original (LO) and with Bence Jones L kappa and L lambda. Only HO + LO restored (minimal) bioactivity. Of isolated TSAb-IgG kappa and TSAb-IgG lambda only IgG lambda was thyroid stimulating. Sub-classes (IgG3 and IgG 1 + 2 + 4) of TSAb-IgG were prepared and with all of 6 sera TSAb was in IgG 1 + 2 + 4 with none in IgG3. These data combine to suggest heterogeneity of this autoimmune antibody.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008135 Long-Acting Thyroid Stimulator An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission. LATS,Thyroid Stimulating Hormone Receptor Autoantibodies,Thyroid Stimulating Hormone Receptor Autoantibody,Thyroid Stimulator, Long-Acting,Thyrotropin Receptor Antibodies,Thyrotropin Receptor Antibody,Thyrotropin Receptor Autoantibodies,Thyrotropin Receptor Autoantibody,Antibody, Thyrotropin Receptor,Autoantibody, Thyrotropin Receptor,Long Acting Thyroid Stimulator,Receptor Antibody, Thyrotropin,Receptor Autoantibody, Thyrotropin,Thyroid Stimulator, Long Acting
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001536 Bence Jones Protein An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA. Bence Jones Protein Den,Bence Jones Protein SUT,Jones Protein, Bence,Protein, Bence Jones

Related Publications

M Zakarija
Thyroid-stimulating antibody in Graves' disease.
June 1984, Lancet (London, England),
M Zakarija
Graves' disease--the thyroid stimulating antibody and immunological networks.
January 1983, Molecular aspects of medicine,
M Zakarija
Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
January 2003, Hormone research,
M Zakarija
Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?
September 1987, Acta endocrinologica,
M Zakarija
Thyroid-stimulating antibody in a patient with euthyroid Graves' disease.
April 2000, Endocrine journal,
M Zakarija
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves' Orbitopathy.
October 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
M Zakarija
Thyroid stimulating immunoglobulin in Graves' disease.
June 1981, Australian and New Zealand journal of medicine,
M Zakarija
Thyroid-stimulating immunoglobulins in Graves' disease.
August 1974, Lancet (London, England),
M Zakarija
Thyroid-stimulating antibodies of Graves' disease in thyroid cancer.
December 1988, The New England journal of medicine,
M Zakarija
Thyroid-stimulating hormone receptor antibody assays: recommendation for correct interpretation of results in Graves disease.
May 2013, Clinical chemistry,
Copied contents to your clipboard!